Alize Pharma

Multinational group of biopharmaceutical companies developing drugs;proteins and peptides

Total raised

€8.3M

€8,300,000

Funding rounds

Investors

distinct backers

Active since

2012-05

latest 2014-08

Funding by year

EUR raised per year

High confidence

Raise-next likelihood18

base rate 44% for Series A

Exit likelihood13

base rate 12% (2+ rounds)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2014-09-01	Series A	€5.0M	Bpifrance	View deal →
2012-06-01	Seed	€3.3M	—	View deal →

same sector or country